Daniel López (Daniel Lopez)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Topics

Immune Response

Endoplasmic Reticulum

Respiratory Syncytial Virus

Top Venues

International journal of molecular sciences

Journal of proteome research

PLoS neglected tropical diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio J Martín-Galiano, Daniel López
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2. International journal of molecular sciences 25 (11) (2024)
Antonio J Martín-Galiano, Daniel López
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2. International journal of molecular sciences 25 (11) (2024)
Antonio J Martín-Galiano, Daniel López
Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2. International journal of molecular sciences 25 (11) (2024)
Daniel López, Marina García-Peydró
Could SARS-CoV-1 Vaccines in the Pipeline Have Contributed to Fighting the COVID-19 Pandemic? Lessons for the Next Coronavirus Plague. Biomedicines 12 (1) (2023)
Daniel López, Marina García-Peydró
Could SARS-CoV-1 Vaccines in the Pipeline Have Contributed to Fighting the COVID-19 Pandemic? Lessons for the Next Coronavirus Plague. Biomedicines 12 (1) (2023)
Daniel López
Prediction of Conserved HLA Class I and Class II Epitopes from SARS-CoV-2 Licensed Vaccines Supports T-Cell Cross-Protection against SARS-CoV-1. Biomedicines 10 (7) (2022)
Anna Foix, Daniel López, Francisco Díez-Fuertes, Michael J McConnell, Antonio Javier Martín-Galiano
Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2. PLoS computational biology 18 (2) (2022)
Ana Tajuelo, Mireia Lopez-Siles, Vicente Más, Pilar Pérez-Romero, José María Aguado, Verónica Briz, Michael J McConnell, Antonio J Martín-Galiano, Daniel López
Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. International journal of molecular sciences 23 (6) (2022)
Elena Lorente, Antonio J Martín-Galiano, Dganit Melamed Kadosh, Alejandro Barriga, Juan García-Arriaza, Carmen Mir, Mariano Esteban, Arie Admon, Daniel López
Abundance, Betweenness Centrality, Hydrophobicity, and Isoelectric Points Are Relevant Factors in the Processing of Parental Proteins of the HLA Class II Ligandome. Journal of proteome research 21 (1) (2021)
Patricia G de la Sota, Elena Lorente, Laura Notario, Carmen Mir, Oscar Zaragoza, Daniel López
Mitoxantrone Shows In Vitro, but Not In Vivo Antiviral Activity against Human Respiratory Syncytial Virus. Biomedicines 9 (9) (2021)
Elena Lorente, Miguel Marcilla, Patricia G de la Sota, Adriana Quijada-Freire, Carmen Mir, Daniel López
Acid Stripping after Infection Improves the Detection of Viral HLA Class I Natural Ligands Identified by Mass Spectrometry. International journal of molecular sciences 22 (19) (2021)
Juan García-Arriaza, Mariano Esteban, Daniel López
Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus. Biomedicines 9 (9) (2021)
Andrés Corral-Lugo, Mireia Lopez-Siles, Daniel López, Michael J McConnell, Antonio J Martin-Galiano
Identification and Analysis of Unstructured, Linear B-Cell Epitopes in SARS-CoV-2 Virion Proteins for Vaccine Development. Vaccines 8 (3) (2020)
Elena Lorente, Antonio J Martín-Galiano, Eilon Barnea, Alejandro Barriga, Concepción Palomo, Juan García-Arriaza, Carmen Mir, Pilar Lauzurica, Mariano Esteban, Arie Admon, Daniel López
Proteomics Analysis Reveals That Structural Proteins of the Virion Core and Involved in Gene Expression Are the Main Source for HLA Class II Ligands in Vaccinia Virus-Infected Cells. Journal of proteome research 18 (3) (2019)
Elena Lorente, Concepción Palomo, Eilon Barnea, Carmen Mir, Margarita Del Val, Arie Admon, Daniel López
Natural Spleen Cell Ligandome in Transporter Antigen Processing-Deficient Mice. Journal of proteome research 18 (9) (2019)
Laura Notario, Jennifer Redondo-Antón, Elisenda Alari-Pahissa, Almudena Albentosa, Magdalena Leiva, Daniel López, Guadalupe Sabio, Pilar Lauzurica
CD69 Targeting Enhances Anti-vaccinia Virus Immunity. Journal of virology 93 (19) (2019)
Antonio J Martín-Galiano, Daniel López
Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells. PloS one 14 (1) (2019)
María Montes-Casado, Gloria Ojeda, Laura Aragoneses-Fenoll, Daniel López, Belén de Andrés, María Luisa Gaspar, Umberto Dianzani, José M Rojo, Pilar Portolés
ICOS deficiency hampers the homeostasis, development and function of NK cells. PloS one 14 (7) (2019)
Elena Lorente, Alejandro Barriga, Eilon Barnea, Concepción Palomo, Juan García-Arriaza, Carmen Mir, Mariano Esteban, Arie Admon, Daniel López
Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence. PLoS neglected tropical diseases 13 (7) (2019)
Elena Lorente, Alejandro Barriga, Juan García-Arriaza, François A Lemonnier, Mariano Esteban, Daniel López
Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein. PLoS neglected tropical diseases 11 (10) (2017)
Elena Lorente, Alejandro Barriga, Eilon Barnea, Carmen Mir, John A Gebe, Arie Admon, Daniel López
Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus. Molecular & cellular proteomics : MCP 15 (6) (2016)